Bright Green Corporation (BGXX)
NASDAQ: BGXX · IEX Real-Time Price · USD
0.244
-0.013 (-5.18%)
At close: Mar 28, 2024, 4:00 PM
0.269
+0.025 (10.26%)
After-hours: Mar 28, 2024, 7:14 PM EDT
Company Description
Bright Green Corporation focuses on the cultivation, manufacture, and sale of cannabis and cannabis-related products.
Its products are used in research, pharmaceutical applications, and affiliated exports. The company was incorporated in 2019 and is based in Grants, New Mexico.
Bright Green Corporation
Country | United States |
IPO Date | May 17, 2022 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 23 |
CEO | Gurvinder Singh |
Contact Details
Address: 401 East Las Olas Blvd., Suite 1400 Ft. Lauderdale, Florida 33301 United States | |
Phone | (201)370-1140 |
Website | brightgreen.us |
Stock Details
Ticker Symbol | BGXX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $8.00 |
CIK Code | 0001886799 |
CUSIP Number | 10920G100 |
ISIN Number | US10920G1004 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Lynn Stockwell | Co-Founder and Chair of the Board |
Saleem Elmasri CPA | Chief Financial Officer |
Gurvinder Singh | Chief Executive Officer and Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 19, 2024 | 8-K | Current Report |
Mar 11, 2024 | 8-K | Current Report |
Feb 22, 2024 | 8-K | Current Report |
Feb 20, 2024 | 8-K | Current Report |
Feb 14, 2024 | 8-K | Current Report |
Dec 7, 2023 | 8-K | Current Report |
Nov 20, 2023 | 10-Q | Quarterly Report |
Nov 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Nov 7, 2023 | DEF 14A | Other definitive proxy statements |
Oct 6, 2023 | 8-K | Current Report |